Ventricular Fibrillation after Bortezomib Therapy in a Patient with Systemic Amyloidosis

A 64-year-old female was diagnosed with systemic amyloidosis associated with multiple myeloma. Bortezomib and dexamethasone-therapy was initiated; however, she developed lethal ventricular fibrillation (VF) and cardiac arrest after 84 hours of therapy. Cardiopulmonary resuscitation using direct curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Satoshi, Muta, Tsuyoshi, Higo, Taiki, Kusumoto, Hirotake, Zaitsu, Eiko, Miyamoto, Toshihiro, Oda, Yoshinao, Akashi, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805163/
https://www.ncbi.nlm.nih.gov/pubmed/24179667
http://dx.doi.org/10.4081/hr.2013.e12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805163/
https://www.ncbi.nlm.nih.gov/pubmed/24179667
http://dx.doi.org/10.4081/hr.2013.e12

Ejemplares similares